Why are pharma MNCs reducing India footprint?

Source: Times Of India Late on Feb 16, Swiss pharma major Novartis made a brief announcement that it had started a “strategic review” of its listed entity, Novartis India Limited, which includes an assessment of its shareholding in the subsidiary. Exactly three months ago, UK biggie AstraZeneca had also announced it was exiting manufacturing in […]